Rhumbline Advisers Csl LTD Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Csl LTD stock. As of the latest transaction made, Rhumbline Advisers holds 16,807 shares of CSLLY stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,807
Previous 16,697
0.66%
Holding current value
$1.45 Million
Previous $1.64 Million
10.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CSLLY
# of Institutions
13Shares Held
128KCall Options Held
0Put Options Held
0-
Boston Common Asset Management, LLC Boston, MA34.6KShares$2.99 Million0.18% of portfolio
-
Thomas White International LTD Chicago, IL30.7KShares$2.64 Million0.6% of portfolio
-
Ramirez Asset Management, Inc. New York, NY22.5KShares$1.94 Million0.43% of portfolio
-
Yousif Capital Management, LLC15KShares$1.29 Million0.01% of portfolio
-
Inverness Counsel LLC2.8KShares$241,4440.01% of portfolio
About CSL LTD
- Ticker CSLLY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 964,432,000
- Market Cap $83.2B
- Description
- CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...